These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2953367)

  • 1. Magnetic resonance imaging for assessment of treatment effects in mediastinal Hodgkin's disease.
    Nyman R; Rehn S; Glimelius B; Hagberg H; Hemmingsson A; Jung B
    Acta Radiol; 1987; 28(2):145-51. PubMed ID: 2953367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnetic resonance in the study of residual mediastinal masses after therapy of lymphoma].
    Davini O; Levis A; Garabello D; Foggetti MD; Depaoli L; Cirillo R; De Lucchi R; Orsucci L; Resegotti L
    Radiol Med; 1992 Mar; 83(3):230-6. PubMed ID: 1579671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cyst of lower mediastinum in a 14-year-old boy with tumor of mediastinum in the course of Hodgkin's disease].
    Gadomski A; Wagiel K
    Wiad Lek; 1998; 51 Suppl 4():331-3. PubMed ID: 10731994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
    Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
    Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI characterization of residual mediastinal masses in Hodgkin's disease: long-term follow-up.
    Di Cesare E; Cerone G; Enrici RM; Tombolini V; Anselmo P; Masciocchi C
    Magn Reson Imaging; 2004 Jan; 22(1):31-8. PubMed ID: 14972392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does the residual mediastinal mass have prognostic significance in children with Hodgkin's disease (HD)?].
    Klekawka T; Balwierz W; Moryl-Bujakowska A; Stanuch H; Matysiak M; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Chaber R; Sońita-Jakimczyki D; Janik-Moszants A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Adamkiewicz-Drozyińska E; Wysocki M; Koltan A; Krawczuk-Rybako M; Muszyńska-Rosłan K; Stolarska M
    Przegl Lek; 2006; 63(1):21-4. PubMed ID: 16892894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The rare differential diagnosis of a mediastinal space-occupying lesion].
    Bohle W; Rüther U; Jipp P
    Dtsch Med Wochenschr; 1999 Mar; 124(9):245-7. PubMed ID: 10102009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign mass lesions after therapy for Hodgkin's disease.
    Durkin W; Durant J
    Arch Intern Med; 1979 Mar; 139(3):333-6. PubMed ID: 426577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Massive skeletal invasion in Hodgkin's disease observed by MRI].
    Suzuki K; Tsuboi I; Inoue M; Sakuma A; Takizawa T; Koyama S; Sawada U; Kitami Y
    Rinsho Ketsueki; 1994 Feb; 35(2):142-7. PubMed ID: 8139111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
    Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Does residual mediastinal mass in children with completed treatment of Hodgkin's disease affect the incidence of relapses?].
    Balwierz W; Armata J; Moryl-Bujakowska A; Depowska T; Bogusławska-Jaworska J; Pisarek J; Sońta-Jakimczyk D; Janik-Moszant A; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Radwańska U; Kołecki P; Kaczmarek-Kanold M; Kowalczyk J; Skomra S; Ochocka M; Matysiak M; Newecka-Samól T
    Wiad Lek; 1998; 51 Suppl 4():12-7. PubMed ID: 10731938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possibilities of radiation-dose reduction in the treatment of Hodgkin's disease. I. Exclusion of the mediastinum from the radiation field in primary high-cervical or infradiaphragmatic involvement and stage I or II (author's transl)].
    Teillet E; Delbrück H; Bayle-Weisgerber C; Andrieu JM; Asselain B; Dana M; Bernard J
    Dtsch Med Wochenschr; 1979 Sep; 104(39):1369-74. PubMed ID: 477568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myocardial infarction after mediastinal radiotherapy of Hodgkin's disease].
    Tres A; Fuertes MA; Callén L; Poderós C; Rodrigo G; Peleato A; Polo J; Gutiérrez M
    Rev Esp Oncol; 1984; 31(3):477-82. PubMed ID: 6546176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presumed intraocular Hodgkin's disease.
    Bishop JE; Salmonsen PC
    Ann Ophthalmol; 1985 Sep; 17(9):589-92. PubMed ID: 4062168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediastinal Hodgkin's disease.
    Vaeth JM; Moskowitz SA; Green JP
    AJR Am J Roentgenol; 1976 Jan; 126(1):123-6. PubMed ID: 175670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
    Noordijk EM; Carde P; Dupouy N; Hagenbeek A; Krol AD; Kluin-Nelemans JC; Tirelli U; Monconduit M; Thomas J; Eghbali H; Aleman BM; Bosq J; Vovk M; Verschueren TA; Pény AM; Girinsky T; Raemaekers JM; Henry-Amar M
    J Clin Oncol; 2006 Jul; 24(19):3128-35. PubMed ID: 16754934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR evaluation of the mediastinal lymph nodes.
    Chakraborti KL; Jena A
    Indian J Chest Dis Allied Sci; 1997; 39(1):19-25. PubMed ID: 9100407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.